In this study, we analyzed the effects of SNPs of LDLR, APOB, and PCSK9 on the risk of PMI in a Chinese Han population not currently undergoing lipid-lowering therapy and evaluated the gene–environment interactions between these SNPs and traditional risk factors for CHD. This evidence concerns the gene PCSK9 and coronary artery disorder.